JULIE SAWYER-MONTGOMERY
PRESIDENT, BECKMAN COULTER DIAGNOSTICS
Julie Sawyer Montgomery was appointed president of Beckman Coulter Diagnostics in 2020 where she has led the company to new levels of growth and innovation in clinical diagnostics, motivated by the mission to Relentlessly Reimagine Healthcare, One Diagnosis at a Time. Beckman Coulter Diagnostics is the largest operating company within Danaher’s Diagnostics platform, driven by a passion to help laboratories achieve excellence in their operations and empower doctors who await critical laboratory test results that change and save the lives of patients.
During her tenure, Beckman Coulter has been recognized as a Top Workplace and Julie was honored by Fierce Pharma as one of the 22 most influential people in the fight against COVID-19.
Prior to her current position, Julie led Beckman Coulter’s developed markets commercial organization, business units and global marketing. Before joining Danaher and Beckman Coulter, Julie served as president of Hospira Infusion Systems, a Pfizer company. Prior to becoming president, Julie’s roles at Hospira included U.S. general management, global marketing, and international sales. Earlier in her career, Julie led marketing strategy for the cardiovascular division of Boston Scientific and served healthcare clients as a project leader for the Boston Consulting Group.
Julie holds a Bachelor of Arts in Economics from Columbia University, a Master of Music from the Eastman School of Music, and a Master of Business Administration from the Harvard Business School. She lives in Orange County, California with her husband and three children.